<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1124</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2019-9-26-28</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>On the verge of an epidemic season</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Prozherina</surname><given-names>Julia</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2019-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2019</year></pub-date><issue>9</issue><fpage>26</fpage><lpage>28</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>The seasonality and course severity of influenza and acute respiratory viral infections (ARVI) have undergone significant changes in recent years. For example, there was no marked increase in the incidence rates over a period of 2018/19 that were traditionally observed in the winter period, which also had an impact on the pharmacy sales of combined anti-cold drugs as one of the most widely used drug groups in the cold season. At the same time, an increasing incidence of colds coincides with not so typical periods, especially at the beginning of autumn.</abstract><kwd-group xml:lang="en"><kwd>flu and acute respiratory viral infections</kwd><kwd>combined cold-relief medicine</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>грипп и ОРВИ</kwd><kwd>комбинированные противопростудные средства</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>О мероприятиях по профилактике гриппа и острых респираторных вирусных инфекций в эпидемическом сезоне 2019-2020 годов. Главный государственный санитарный врач РФ. Постановление №10 от 10.07.2019.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Инструкция по применению к препарату АнвиМакс®.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Лусс Л.В. Комплексный подход к терапии гриппа и ОРВИ. Медицинский. совет. 2017;(5):168-173.</mixed-citation></ref></ref-list></back></article>
